Late Campylobacter jejuni mastitis after augmentation mammoplasty

ABSTRACT: Breast implant-associated infections (BIAI) occur in approximately 2% of patients after augmentation mammoplasty. In some cases, BIAI can be treated conservatively, whereas others need implant removal. Knowledge of uncommon potential pathogens in BIAI is important to ensure optimal treatme...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tomas Vedin, Henrik Bergenfeldt
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/bf419d8e71e346b09b7421a266930923
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bf419d8e71e346b09b7421a266930923
record_format dspace
spelling oai:doaj.org-article:bf419d8e71e346b09b7421a2669309232021-12-02T05:01:59ZLate Campylobacter jejuni mastitis after augmentation mammoplasty2352-587810.1016/j.jpra.2021.06.004https://doaj.org/article/bf419d8e71e346b09b7421a2669309232021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2352587821000589https://doaj.org/toc/2352-5878ABSTRACT: Breast implant-associated infections (BIAI) occur in approximately 2% of patients after augmentation mammoplasty. In some cases, BIAI can be treated conservatively, whereas others need implant removal. Knowledge of uncommon potential pathogens in BIAI is important to ensure optimal treatment of BIAI. In the present case report, we describe a case of bilateral late Campylobacter jejuni mastitis in a 34-year-old woman without previous symptoms of gastroenteritis. While Staphylococci are common causative pathogens in BIAI, there are numerous potential pathogens. This case highlights the importance of careful consideration of antibiotic treatment and switch to broad-spectrum antibiotic regimen in BIAI not responding to initial treatment.Tomas VedinHenrik BergenfeldtElsevierarticleAugmentation mammoplastyBreast-Implant associated infectionsCampylobacterSurgeryRD1-811ENJPRAS Open, Vol 30, Iss , Pp 13-16 (2021)
institution DOAJ
collection DOAJ
language EN
topic Augmentation mammoplasty
Breast-Implant associated infections
Campylobacter
Surgery
RD1-811
spellingShingle Augmentation mammoplasty
Breast-Implant associated infections
Campylobacter
Surgery
RD1-811
Tomas Vedin
Henrik Bergenfeldt
Late Campylobacter jejuni mastitis after augmentation mammoplasty
description ABSTRACT: Breast implant-associated infections (BIAI) occur in approximately 2% of patients after augmentation mammoplasty. In some cases, BIAI can be treated conservatively, whereas others need implant removal. Knowledge of uncommon potential pathogens in BIAI is important to ensure optimal treatment of BIAI. In the present case report, we describe a case of bilateral late Campylobacter jejuni mastitis in a 34-year-old woman without previous symptoms of gastroenteritis. While Staphylococci are common causative pathogens in BIAI, there are numerous potential pathogens. This case highlights the importance of careful consideration of antibiotic treatment and switch to broad-spectrum antibiotic regimen in BIAI not responding to initial treatment.
format article
author Tomas Vedin
Henrik Bergenfeldt
author_facet Tomas Vedin
Henrik Bergenfeldt
author_sort Tomas Vedin
title Late Campylobacter jejuni mastitis after augmentation mammoplasty
title_short Late Campylobacter jejuni mastitis after augmentation mammoplasty
title_full Late Campylobacter jejuni mastitis after augmentation mammoplasty
title_fullStr Late Campylobacter jejuni mastitis after augmentation mammoplasty
title_full_unstemmed Late Campylobacter jejuni mastitis after augmentation mammoplasty
title_sort late campylobacter jejuni mastitis after augmentation mammoplasty
publisher Elsevier
publishDate 2021
url https://doaj.org/article/bf419d8e71e346b09b7421a266930923
work_keys_str_mv AT tomasvedin latecampylobacterjejunimastitisafteraugmentationmammoplasty
AT henrikbergenfeldt latecampylobacterjejunimastitisafteraugmentationmammoplasty
_version_ 1718400792942084096